M-Son Spary - 50 mcg/Spray

Nasal Spray

Pack Size : 1 Bottle x 1 Packet

Generics : Mometasone Furoate

Manufacturer : Drug International Ltd.

Best Price * TK 250.00

* Delivery will be done in Dhaka city only.

Alternative Product

Cream Soneta - 30gm Aristopharma Limited

Tk 500.00

Nasal Spray Metaspray Nasal Spray - Square Pharmaceuticals Ltd.

Tk 251.70

Nasal Spray Momeson Nasal Spray - 50mcg Incepta Pharmaceuticals Ltd.

Tk 250.00

Spray Nasonex 50mg/5ml Opsonin Pharma Limited

Tk 250.00

More Information About - M-Son Spary - 50 mcg/Spray

Description

Generic Name

Mometasone Furoate

Precaution

Respiratory tract tuberculosis, untreated fungal or bacterial infections, viral or parasitic infections, ocular herpes simplex Nasal septum perforation, epistaxis, wheezing Cataracts, glaucoma, increased intraocular pressure Risk of more serious or fatal course of chickenpox and measles in susceptible individuals; avoid use in unvaccinated or immunologically unexposed children or adults Deaths from adrenal insufficiency have occurred after abrupt withdrawal of oral steroids; taper withdrawal gradually May retard growth in children Immunocompromised patients Infections of nose and pharynx, including Candida albicans Excessive use may suppress hypothalamic-pituitary-adrenal function During periods of stress or severe status asthmaticus, patient may require supplementary systemic corticosteroids immediately; carry warning card to that effect Long-term administration reduces bone mineral density

Indication

Allergic rhinitis, Nasal polyps, Asthma prophylaxis

Contra Indication

Hypersensitivity, Immunosuppressed patients, Tuberculosis, Status asthmaticus or other acute asthma episode necessitating intensive measures, Known hypersensitivity to milk proteins or any other ingredients

Dose

N/A

Side Effect

>10% Headache (26%),Viral infection (14%),Pharyngitis (12%),Epistaxis (11%) 1-10% Cough (7%),Upper respiratory tract infection (6%),Dysmenorrhea (5%) Frequency Not Defined Loss of taste,Muscle soreness

Pregnancy Category

Name : Not Classified

Description

FDA has not yet classified the drug into a specified pregnancy category.

Mode of Action

Mometasone depresses the formation, release and activity of endogenous inflammatory chemical mediators (e.g. kinins, histamine, liposomal enzymes and prostaglandin). It inhibits the margination and subsequent cell migration to the injury site, reverses vascular dilatation and permeability, resulting in decreased access of cells to the area of injury.

Interaction

Increased risk of hypokalaemia with amphotericin B, potassium-wasting diuretics. Decreases hypoglycaemic effects of antidiabetic drugs. Increased serum levels with antifungals (imidazole). Increased risk of tendinopathies with fluoroquinolones.

Pregnancy Category Note

Pregnancy Inhalation There are no randomized clinical studies in pregnant women Clinical considerations In women with poorly or moderately controlled asthma, there is an increased risk of several perinatal adverse outcomes such as preeclampsia in the mother and prematurity, low birth weight, and small for gestational age in the neonate Closely monitor pregnant women with asthma and adjust medication as necessary to maintain optimal asthma control Lactation There are no available data on the presence in human milk, the effects on the breastfed child, or the effects on milk production Other inhaled corticosteroids, similar to mometasone furoate, are present in human milk Consider developmental and health benefits of breastfeeding along with the mother?s clinical need and any potential adverse effects on the breastfed infant from mometasone inhaled or from the underlying maternal condition Nasal Pregnancy category: C Lactation: Unknown whether distributed in breast milk

Adult Dose

Nasal Allergic rhinitis Adult: Nasal Treatment and prophylaxis of allergic rhinitis Adults: 100 mcg (2 sprays) in each nostril once daily, increased to 200 mcg into each nostril once daily if needed. Maintenance: 50 mcg in each nostril daily. In patients with a known seasonal allergen that precipitates nasal symptoms of seasonal allergic rhinitis, prophylaxis with Mometasone Nasal Spray is recommended 2 to 4 weeks prior to the anticipated start of the pollen season. Nasal polyps: 100 mcg (2 sprays) in each nostril once daily; may increase to bid after 5-6 wk if needed. Inhalation Asthma prophylaxis: Mild to moderate: Initially, 400 mcg once daily in the evening. Maintenance: 200 mcg once to bid. Severe: Initially, 400 mcg bid, then titrated to lowest effective dose once controlled. Child: Mild to moderate: Initially, 400 mcg once daily. Maintenance: 200 mcg once to bid. Severe: Initially, 400 mcg bid, then titrated to lowest effective dose once controlled.

Child Dose

Nasal Allergic rhinitis Child: 2-11 yr: 50 mcg (1 spray) in each nostril daily; Child: >12 yr: 100 mcg in each nostril daily. Inhalation Asthma prophylaxis: Child: Mild to moderate: Initially, 400 mcg once daily. Maintenance: 200 mcg once to bid. Severe: Initially, 400 mcg bid, then titrated to lowest effective dose once controlled.

Renal Dose

N/A

Administration

N/A

Disclaimer

The information provided herein are for informational purposes only and not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please note that this information should not be treated as a replacement for physical medical consultation or advice. Great effort has been placed to provide accurate and comprehensive data. However, Medicart along with its authors and editors make no representations or warranties and specifically disclaim all liability for any medical information provided on the site. The absence of any information and/or warning to any drug shall not be considered and assumed as an implied assurance of the Company.